171 related articles for article (PubMed ID: 37067392)
1. Withaferin A inhibits breast cancer-induced osteoclast differentiation.
Hahm ER; Kim SH; Singh SV
Mol Carcinog; 2023 Jul; 62(7):1051-1061. PubMed ID: 37067392
[TBL] [Abstract][Full Text] [Related]
2. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
Lee J; Hahm ER; Singh SV
Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation.
Hahm ER; Kim SH; Pore SK; Mathan SV; Singh RP; Singh SV
Mol Carcinog; 2024 Feb; 63(2):301-313. PubMed ID: 37921547
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
Lee J; Hahm ER; Marcus AI; Singh SV
Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
[TBL] [Abstract][Full Text] [Related]
5. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
6. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
Hahm ER; Kim SH; Singh KB; Singh SV
Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
[TBL] [Abstract][Full Text] [Related]
7. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
Hahm ER; Lee J; Huang Y; Singh SV
Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone.
Khedgikar V; Kushwaha P; Gautam J; Verma A; Changkija B; Kumar A; Sharma S; Nagar GK; Singh D; Trivedi PK; Sangwan NS; Mishra PR; Trivedi R
Cell Death Dis; 2013 Aug; 4(8):e778. PubMed ID: 23969857
[TBL] [Abstract][Full Text] [Related]
9. Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics.
Sehrawat A; Samanta SK; Hahm ER; St Croix C; Watkins S; Singh SV
Mitochondrion; 2019 Jul; 47():282-293. PubMed ID: 30685490
[TBL] [Abstract][Full Text] [Related]
10. Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate.
Pore SK; Hahm ER; Latoche JD; Anderson CJ; Shuai Y; Singh SV
Carcinogenesis; 2018 Feb; 39(2):134-145. PubMed ID: 29040431
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.
Hahm ER; Moura MB; Kelley EE; Van Houten B; Shiva S; Singh SV
PLoS One; 2011; 6(8):e23354. PubMed ID: 21853114
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
Stan SD; Hahm ER; Warin R; Singh SV
Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155
[TBL] [Abstract][Full Text] [Related]
13. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
Hahm ER; Lee J; Abella T; Singh SV
Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
15. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.
Hahm ER; Singh SV
Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
17. Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
Samanta SK; Sehrawat A; Kim SH; Hahm ER; Shuai Y; Roy R; Pore SK; Singh KB; Christner SM; Beumer JH; Davidson NE; Singh SV
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28040797
[TBL] [Abstract][Full Text] [Related]
18. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
[TBL] [Abstract][Full Text] [Related]
19. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.
Liverani C; Mercatali L; Spadazzi C; La Manna F; De Vita A; Riva N; Calpona S; Ricci M; Bongiovanni A; Gunelli E; Zanoni M; Fabbri F; Zoli W; Amadori D; Ibrahim T
Bone; 2014 Sep; 66():214-22. PubMed ID: 24956020
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]